About Realcade Lifescience Private Limited
Data last updated: 22 December 2025
Realcade Lifescience Private Limited is a private limited company based in Kadi, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 14 May 2012, the company has been in operation for over 14 years.
Registered with ROC Ahmedabad under CIN U24233GJ2012PTC070297.
Capital: an authorised share capital of ₹21 Cr and a paid-up capital of ₹21 Cr. Formerly known as Realkind Lifesciences Private Limited. It is led by directors including Chetankumar Mahendrakumar Patel and Rumit Vinodbhai Patel.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Revenue Survey No.891 - 892 Nr. Y-Junction Narmada Canal Karannagar, Kadi, Gujarat, India – 382715.
As per the financials filed for FY 2025, the company reported a revenue of ₹122.35 Cr, a growth of 8% compared to the previous year.
The company has a workforce of approximately 298 employees as per the latest available data.
The company is associated with 1 brand — Realcade Lifescience. As per MCA filings, the company has open charges of ₹69.01 Cr and satisfied charges of ₹89.5 Cr on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website realcadelifescience.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered AddressRevenue Survey No.891 - 892 Nr. Y-Junction Narmada Canal Karannagar, Kadi, Gujarat, India – 382715
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Realcade Lifescience Private Limited
Realcade Lifescience Private Limited operates one associated brand: Realcade Lifescience. These brands represent Realcade Lifescience Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of IV fluids and pharmaceutical formulations in Gujarat, India. | realcadelifescience.com |
Business Activity of Realcade Lifescience Private Limited
Realcade Lifescience Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Realcade Lifescience Private Limited
Realcade Lifescience Private Limited is audited by BRIJESH A PATEL & CO. for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BRIJESH A PATEL & CO. | blur-value | blur-value | blur-value |
Board of Directors of Realcade Lifescience Private Limited
Realcade Lifescience Private Limited is governed by 6 directors who oversee the company's operations and strategic decisions.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chetankumar Mahendrakumar Patel | Director | 20 Jan 2014 | 12 Years 5 Months | Current |
|
Rumit Vinodbhai Patel
Also directs:
Marvella Foods Private Limited, Jv Lifescience Private Limited
|
Director | 20 Jan 2014 | 12 Years 5 Months | Current |
|
Bharatkumar Baluji Vihol
Also directs:
Realcade Global Llp, Harsh Medicose Private Limited, Padmaja Lifescience Private Limited and 1 more
|
Director | 24 Oct 2013 | 12 Years 8 Months | Current |
|
Rahulkumar Mahendrabhai Patel
Also directs:
Marvella Foods Private Limited, Jug Packaging Private Limited
|
Director | 14 May 2012 | 14 Years 1 Months | Current |
|
Vinodkumar Ranchhodbhai Patel
Also directs:
Marvella Foods Private Limited, Vyom Fasteners Private Limited
|
Director | 14 May 2012 | 14 Years 1 Months | Current |
Financials of Realcade Lifescience Private Limited FY 2024 filings available
Realcade Lifescience Private Limited reported revenue of ₹122.35 Cr (up 8% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Realcade Lifescience Private Limited
As of FY 2023, Realcade Lifescience Private Limited's shareholding pattern shows 48.48% by promoters, 51.52% by public shareholders. Public shareholders hold the majority stake, reflecting broad public ownership.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Realcade Lifescience Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Aug 2023 | Hdfc Bank Limited | ₹24.6 Lakh | Open |
| 19 Jan 2021 | Hdfc Bank Limited | ₹55.13 Cr | Open |
| 31 Oct 2015 | State Bank of India | ₹13.64 Cr | Open |
| 10 Jan 2020 | Hdfc Bank Limited | ₹25.5 Cr | Satisfied |
| 25 Oct 2019 | Others | ₹34 Cr | Satisfied |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Realcade Lifescience Private Limited
Realcade Lifescience Private Limited has a workforce of 298 employees as of Apr 07, 2024.
Employee Count & EPFO Data of Realcade Lifescience Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Realcade Lifescience Private Limited
GSTIN & GST Filing Data of Realcade Lifescience Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Realcade Lifescience Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Realcade Lifescience Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Realcade Lifescience Private Limited
MSME Payment Delays by Realcade Lifescience Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Realcade Lifescience Private Limited
Subsidiaries & Group Companies of Realcade Lifescience Private Limited
See the full corporate group — holding company, subsidiaries, associates and joint ventures of Realcade Lifescience Private Limited with ownership details.
MCA Filings & Documents of Realcade Lifescience Private Limited
MCA Filings & Documents of Realcade Lifescience Private Limited
Download official documents filed with the Ministry of Corporate Affairs — from incorporation papers to the latest annual filings.
Recent Activity on Realcade Lifescience Private Limited
Frequently Asked Questions about Realcade Lifescience Private Limited
Realcade Lifescience Private Limited is an active private limited company in the pharma sector based in Kadi, Gujarat, India. It was incorporated on 14 May 2012 (14+ years old) and is registered under CIN U24233GJ2012PTC070297. The company has 298 employees.
Realcade Lifescience Private Limited reported revenue of ₹122.35 Cr for FY 2025 (up 8.00% YoY).
The current directors of Realcade Lifescience Private Limited are:
The primary industry of Realcade Lifescience Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Realcade Lifescience Private Limited can be reached at the registered office: Revenue Survey No.891 - 892 Nr. Y-Junction Narmada Canal Karannagar, Kadi, Gujarat, India – 382715, or through the website realcadelifescience.com.
The authorised capital is ₹21 Cr, and the paid-up capital is ₹21 Cr.